MedTrace Logo

A Feasibility Study Exploring the Effect of Remicade on the Disease Activity in RA Patients (Study P05417)

NCT00741104 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 363

Last updated 2017-01-04

Study results available
· View outcomes & findings →

Summary

This observational study will explore the Swedish national population of patients with rheumatoid arthritis (RA) on infliximab maintenance therapy in order to identify patients who may be eligible for a dose reduction study. Patients will be asked a variety of questions regarding their treatment dosing and disease activity, and then asked whether or not they would consider participating in a dose reduction study. Patients in this study will be described in terms of demographic and disease characteristics.

Conditions

Interventions

DRUG

Infliximab

Treatment of RA with Infliximab according to and under normal routine clinical practice.

Sponsors & Collaborators

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2008-06-30
Completion
2008-06-30

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00741104 on ClinicalTrials.gov